Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study
Public ClinicalTrials.gov record NCT01987453. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Study To Evaluate The Efficacy And Safety Of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin For 12 or 24 Weeks In Chronic Genotype 1 HCV Infected Subjects Who Participated In A Prior Gilead-Sponsored HCV Treatment Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of this study are to evaluate the efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) with or without ribavirin (RBV) in participants with chronic genotype 1 hepatitis C virus (HCV) infection who have participated in a prior Gilead-sponsored HCV treatment study, and who did not achieve sustained virologic response (SVR24), defined as HCV RNA \< lower limit of quantification (LLOQ) 24 weeks after last dose of study drug (SVR24).
Study identification
- NCT ID
- NCT01987453
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Type not available)
- Primary completion
- Nov 2015 (Actual)
- Completion
- Nov 2015 (Actual)
- Last update posted
- Nov 19, 2018
2014 – 2015
United States locations
- U.S. sites
- 39
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Beverly Hills | California | 90210 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Los Angeles | California | 90036 | — |
| Not listed | Los Angeles | California | 90069 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Washington D.C. | District of Columbia | 20009 | — |
| Not listed | Gainesville | Florida | 32610 | — |
| Not listed | Jacksonville | Florida | 32256 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Downers Grove | Illinois | 60515 | — |
| Not listed | Indianapolis | Indiana | 46237 | — |
| Not listed | Bowling Green | Kentucky | 42101 | — |
| Not listed | Baton Rouge | Louisiana | 70809 | — |
| Not listed | Baltimore | Maryland | 21229 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Springfield | Massachusetts | 01105 | — |
| Not listed | Minneapolis | Minnesota | 55414 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | Hillsborough | New Jersey | 08844 | — |
| Not listed | Albuquerque | New Mexico | 87131 | — |
| Not listed | Binghamton | New York | 13903 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | Asheville | North Carolina | 28801 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Germantown | Tennessee | 38138 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
| Not listed | Richmond | Virginia | 23226 | — |
| Not listed | Seattle | Washington | 98111 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01987453, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2018 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01987453 live on ClinicalTrials.gov.